Here's Why Repligen Stock Gained 12.8% in March
The bioprocess company was a rare bright spot for investors, although the worst is likely yet to come for the stock.
Here's Why Zoetis Stock Fell 11.7% in March
The animal health company outperformed the S&P 500 last month. As of early April, it has also gained back most of its losses.
Here's Why Tyson Foods Stock Dropped 14.7% in March
The food producer is an essential business, but it hasn't been spared by COVID-19.
Here's Why Guardant Health Fell 20% in March
Growth stocks were among the worst performers during last month's correction.
Here's Why Viking Therapeutics Tumbled 20.9% in March
The small-cap pharma stock didn't stand a chance in the broader market volatility.
2 Top U.S. Stocks to Watch in April
These two stocks can be used to gauge how the pharmaceutical industry and energy sector are faring during the coronavirus pandemic -- and what might be ahead.
Stocks to Watch in April
An under-the-radar technology platform active in the fight against coronavirus and a leading electric utility are important stocks to keep an eye on this month.
My Top Biotech Stocks to Buy in the Market Crash
The worst may be yet to come for the stock market, but these biopharma companies have promising potential.
Here's Why Deciphera Pharmaceuticals Lost 22.7% in March
Investors are concerned that an important regulatory deadline for the development-stage drug developer will be delayed because of the coronavirus pandemic.
Here's Why Epizyme Lost 27.6% in March
Investors were looking forward to the drug company's transition to commercial operations, but the coronavirus pandemic could delay the maturation process.
Here's Why Albemarle Stock Fell 31.1% in March
The world's largest lithium producer was bracing for a difficult 2020. Then the coronavirus pandemic hit.
Here's Why Invitae Tumbled 32.9% in March
Growth stocks were among the most severely punished during the recent stock market crash.
Here's Why Bloom Energy Fell 42.3% in March
The stock's compounding momentum proved no match for the coronavirus pandemic.
Here's Why Fate Therapeutics Rose as Much as 18.7% Today
The cellular therapy developer announced an equity investment from and a partnership with Janssen, a subsidiary of Johnson & Johnson.
Gold Stocks Soared Thursday as Investors Digested Sour Economic Data
Precious metals are thriving on the current economic upheaval.
Alliance Resource Partners Soared Today After Touching 20-Year Lows
Despite today's bounce, the coal producer faces an uncertain path ahead.
Here's Why Invitae Stock Is Swinging Wildly Today
The company announced the pricing of a public offering of common stock.
U.S. Coal-Fired Power Plants Stumbled Into 2020
Electricity generation from coal fell 35% in January 2020 from the year-ago period.
So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature
Success in clinical trials doesn't guarantee success on the market.
Here's Why Alliance Resource Partners Stock Fell as Much as 13.9% Today
The company announced actions in response to the global economic slowdown caused by the coronavirus.